Apex Biotechnology Corp. (TPE:1733)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
27.45
+0.10 (0.37%)
Jul 11, 2025, 1:30 PM CST
-23.43%
Market Cap 2.74B
Revenue (ttm) 1.96B
Net Income (ttm) 160.88M
Shares Out 99.95M
EPS (ttm) 1.60
PE Ratio 17.16
Forward PE n/a
Dividend 1.20 (4.37%)
Ex-Dividend Date Jun 11, 2025
Volume 119,296
Average Volume 117,721
Open 27.10
Previous Close 27.35
Day's Range 27.10 - 27.50
52-Week Range 26.40 - 36.10
Beta 0.21
RSI 30.60
Earnings Date Aug 8, 2025

About Apex Biotechnology

Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing, and hemosmart gold hemoglobin screening systems. It also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is headquartered in Hsinchu City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1733
Full Company Profile

Financial Performance

In 2024, Apex Biotechnology's revenue was 1.85 billion, an increase of 10.48% compared to the previous year's 1.68 billion. Earnings were 128.00 million, an increase of 10.55%.

Financial Statements

News

There is no news available yet.